# Arcalyst

NDC: 73604-914
Generic name: rilonacept
Labeler / Manufacturer: Kiniksa Pharmaceuticals (UK), Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20080227

FDA application: BLA125249

## Active ingredients

- RILONACEPT: 160 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73604-914"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73604-914
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ad965f38-dd22-4607-a673-2fb92f3b527a